Biohm Technologies secures $4.52M funding to drive next phase of growth
Summary
Part of the way the funding helps fuel our next phase of growth is by enabling us to bring on top industry talent to harness our microbiome database and further build out our AI platform for new ingredient identification and product development, Kristin Wilhoyte, vice president of B2B marketing, told NutraIngredients.The latest funding round included investment by Luxembourg-based Praesidium, which promotes environmental and social sustainability in the agriculture and food industries, and Sparkfood by Sonae, a multinational Portuguese holding.At Sparkfood, we invest in groundbreaking companies that push the boundaries of health and microbiome science, said Jean-Baptiste Bachelerie, CEO of Sparkfood. Biohm Technologies is at the forefront of this space, pioneering solutions that integrate bacterial and fungal research to transform gut health. Biohm Technologies also offers its comprehensive microbiome gut testing kits as a private label solution for brands in the health and wellness space.The companys data-driven methodology, called Symbiont, is the basis for the development and commercialization of ingredients validated through clinical trials. The companys flagship ingredient is Mycohsa, a probiotic blend shown to break down digestive biofilms and support bacteria and yeast levels for gut health.New VP of Science and TechnologyBiohm announced the appointment of Dr. John Deaton last week, noting that he is tasked with leading the expansion of microbiome technology solutions, including ingredients, gut health testing, and data-driven supplement formulations.Dr. Deaton brings more than 17 years of expertise in microbial and enzyme research, with a career spanning probiotics, prebiotics and biotechnological applications.